GUD.TSX
Knight Therapeutics Inc

351
Mkt Cap
$730.36M
Volume
85,589.00
52W High
$7.50
52W Low
$5.43
PE Ratio
-139.25
GUD.TSX Fundamentals
Price
$7.45
Prev Close
$7.44
Open
$7.44
50D MA
$6.32
Beta
0.46
Avg. Volume
98,981.09
EPS (Annual)
-$0.054
P/B
0.96
Rev/Employee
$542,274.70
$585.01
Loading...
Loading...

About

Knight Therapeutics, Inc. engages in the business of acquiring, in licensing, out-licensing, marketing, and commercializing pharmaceuticals products. The firm also focuses on building a portfolio of innovative products through in-licensing or acquiring product rights. The company was founded by Jonathan Ross Goodman on November 1, 2013 and is headquartered in Montréal, Canada.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
830

Frequently Asked Questions

What is Market Cap of Knight Therapeutics Inc?
What is the 52-week high for Knight Therapeutics Inc?
What is the 52-week low for Knight Therapeutics Inc?
What is Knight Therapeutics Inc stock price today?
What was Knight Therapeutics Inc stock price yesterday?
What is the PE ratio of Knight Therapeutics Inc?
What is the Price-to-Book ratio of Knight Therapeutics Inc?
What is the 50-day moving average of Knight Therapeutics Inc?
How many employees does Knight Therapeutics Inc have?

Latest GUD.TSX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.